Prenatal exposure to GLP-1 receptor agonists may not pose greater risk than insulinInfants born to women with pre-gestational type 2 diabetes who take second-line non-insulin antidiabetic medications (ADMs) during...
Tirzepatide found to reduce body weight regardless of duration of condition and BMI before treatment5 days ago